Literature DB >> 30113730

All-Inorganic Perovskite CsSnBr3 as a Thermally Stable, Free-Carrier Semiconductor.

Binghan Li1,2,3, Ruiying Long1,2,3, Yu Xia1, Qixi Mi1.   

Abstract

Hybrid organic-inorganic perovskites, especially methylammonium lead triiodide (MAPbI3 ), are intensely studied for their optoelectronic properties. The organic MA+ cation is held responsible for the superior performance of MAPbI3 but also its instability toward moisture and heat. To explore compositions beyond MAPbI3 , we performed experiments and calculations on two isomorphous perovskites CsSnBr3 and MASnBr3 . CsSnBr3 is slightly smaller than MASnBr3 in cell dimension, but outperforms MASnBr3 in band gap energy, charge-carrier reduced effective mass, and optical dielectric constant all by ≈19 %. These merits accumulate to drastically cut the exciton binding energy from 33 meV for MASnBr3 to 19.6 meV for CsSnBr3 , making CsSnBr3 a black, free-carrier semiconductor. CsSnBr3 also exhibits distinctly higher stability toward moisture and heat than its organic counterparts. These advantages suggest ecofriendly applications for CsSnBr3 , such as tandem solar cells and direct X-ray detectors.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cesium; perovskite phases; semiconductors; structure-activity relationships; tin

Year:  2018        PMID: 30113730     DOI: 10.1002/anie.201807674

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Underestimated Color Centers: Defects as Useful Reducing Agents in Lanthanide-Activated Luminescent Materials.

Authors:  Markus Suta; Flavie Lavoie-Cardinal; Claudia Wickleder
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-23       Impact factor: 15.336

2.  Inhibition of Phase Segregation in Cesium Lead Mixed-Halide Perovskites by B-Site Doping.

Authors:  Daocheng Hong; Peiyang Zhao; Yu Du; Cheng Zhao; Yuren Xia; Zhihong Wei; Zhong Jin; Yuxi Tian
Journal:  iScience       Date:  2020-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.